4-Amino-N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)butanamide hydrochloride

Catalog No.: 
ACFZBP249
CAS No.: 
2839138-69-9
Molecular Formula: 
C17H21ClN4O4
Molecular Weight: 
380.83
4-Amino-N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)butanamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$184.00In stockInquiry
100mg95%$275.00In stockInquiry
250mg95%$392.00In stockInquiry
1g95%$791.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Amino-N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)butanamide hydrochloride
IUPAC Name4-amino-N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)butanamide hydrochloride
Molecular FormulaC17H21ClN4O4
Molecular Weight380.83
SMILESO=C(NC1=CC=CC2=C1CN(C(CC3)C(NC3=O)=O)C2=O)CCCN.[H]Cl
InChI KeyHKOHLFRUGCCJKA-UHFFFAOYSA-N
CAS No.2839138-69-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFZBP249 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYPFE829 route compound structure diagram
    ACYPFE82927219-07-4In Stock
  2. Then
  3. ACFZBP249 route product structure diagram
    ACFZBP2492839138-69-9In Stock
Inquiry

2. ACFZBP249 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFZBP249 route product structure diagram
    ACFZBP2492839138-69-9In Stock
Inquiry

3. ACFZBP249 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFZBP249 route product structure diagram
    ACFZBP2492839138-69-9In Stock
Inquiry

Comments (0)